BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

983 related articles for article (PubMed ID: 30907226)

  • 1. Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity.
    Park JS; Lee DH; Lee YS; Oh E; Bae KH; Oh KJ; Kim H; Bae SH
    Autophagy; 2020 Jan; 16(1):86-105. PubMed ID: 30907226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
    Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
    Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-coverage regulations of autophagy by ROS: from induction to maturation.
    Zhou J; Li XY; Liu YJ; Feng J; Wu Y; Shen HM; Lu GD
    Autophagy; 2022 Jun; 18(6):1240-1255. PubMed ID: 34662529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway.
    Lee DH; Park JS; Lee YS; Bae SH
    Redox Biol; 2022 Apr; 50():102235. PubMed ID: 35091323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.
    Deng Z; Lim J; Wang Q; Purtell K; Wu S; Palomo GM; Tan H; Manfredi G; Zhao Y; Peng J; Hu B; Chen S; Yue Z
    Autophagy; 2020 May; 16(5):917-931. PubMed ID: 31362587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation.
    Gilardini Montani MS; Santarelli R; Granato M; Gonnella R; Torrisi MR; Faggioni A; Cirone M
    Autophagy; 2019 Apr; 15(4):652-667. PubMed ID: 30324853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
    Park JS; Kang DH; Lee DH; Bae SH
    Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
    Yao RQ; Ren C; Xia ZF; Yao YM
    Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation.
    Li S; Li J; Shen C; Zhang X; Sun S; Cho M; Sun C; Song Z
    Biochim Biophys Acta; 2014 Jan; 1841(1):22-33. PubMed ID: 24055888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain.
    Li J; Tian M; Hua T; Wang H; Yang M; Li W; Zhang X; Yuan H
    Autophagy; 2021 Dec; 17(12):4062-4082. PubMed ID: 33834930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity.
    Hall BS; Dos Santos SJ; Hsieh LT; Manifava M; Ruf MT; Pluschke G; Ktistakis N; Simmonds RE
    Autophagy; 2022 Apr; 18(4):841-859. PubMed ID: 34424124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
    Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
    J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging views of mitophagy in immunity and autoimmune diseases.
    Xu Y; Shen J; Ran Z
    Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in age-related macular degeneration.
    Kaarniranta K; Blasiak J; Liton P; Boulton M; Klionsky DJ; Sinha D
    Autophagy; 2023 Feb; 19(2):388-400. PubMed ID: 35468037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
    Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus induces autophagic signaling independent of the ULK1 complex.
    Corona Velazquez A; Corona AK; Klein KA; Jackson WT
    Autophagy; 2018; 14(7):1201-1213. PubMed ID: 29929428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.